MKI67 and cancer: Using a cut off value of > 13% positively stained cancer cells, pCRs were observed in 113 of 390 patients (29%) with a high proliferative status as assessed by Ki67 and in seven of 162 patients (4.3%) with a low proliferative status (Table 1).